ethyl methanesulfonate has been researched along with HIV Coinfection in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blackburn, R; Golding, H; Hillman, K; Manischewitz, J; Norcross, M; Qian, J; Roderiquez, G; Siegel, JN | 1 |
1 other study(ies) available for ethyl methanesulfonate and HIV Coinfection
Article | Year |
---|---|
Reduced susceptibility to HIV-1 infection of ethyl-methanesulfonate-treated CEM subclones correlates with a blockade in their protein kinase C signaling pathway.
Topics: Base Sequence; CD4-Positive T-Lymphocytes; Cell Compartmentation; Cells, Cultured; Clone Cells; Cytoplasm; DNA-Binding Proteins; Ethers, Cyclic; Ethyl Methanesulfonate; Gene Expression; HIV Infections; HIV Long Terminal Repeat; Humans; In Vitro Techniques; Molecular Sequence Data; Mutation; NF-kappa B; Nuclear Proteins; Okadaic Acid; Protein Kinase C; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-raf; Signal Transduction; Tetradecanoylphorbol Acetate | 1992 |